| Financial Year |
March 31 2023 |
| Monetary Funds |
193,849,244.77 |
| Held-for-trading Financial Assets |
23,890.24 |
| Notes Receivable |
13,589,664.68 |
| Accounts Receivable |
503,018,288.33 |
| Advances to Suppliers |
15,864,135.22 |
| Other Receivables |
6,195,778.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
305,389,158.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
769,474.85 |
| Total Current Assets |
1,055,796,806.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,410,178.63 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
114,338,070.72 |
| Under-construction Projects |
38,751.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,125,071.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
809,943.30 |
| Deferred Income Tax Assets |
36,734,428.87 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
189,572,821.58 |
| Total Assets |
1,245,369,627.79 |
| Short-Term Loans |
83,163,571.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,224,530.02 |
| Accounts Payable |
94,235,502.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,915,875.53 |
| Taxes Payable |
8,698,017.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,009,350.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,291,192.80 |
| Other Current Liabilities |
372,903.67 |
| Sub-Total of Current Liabilities |
249,038,353.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,414,903.18 |
| Deferred Income Tax Liabilities |
629,462.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,710,416.26 |
| Total Liabilities |
271,748,770.23 |
| Paid-In Capital(Or Share Stock) |
255,225,750.00 |
| Capital Surplus |
475,377,140.27 |
| Surplus Reserve |
42,516,311.69 |
| LESS:Treasury Stock |
9,922,510.00 |
| Undistributed Profits |
210,424,165.60 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
973,620,857.56 |
| Owner's Equity（Stockholder's Equity） |
973,620,857.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,245,369,627.79 |
